FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

19338005: 2 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    32597014 Two en Synonym Active Entire term case insensitive SNOMED CT core module
    3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442103019 2 en Synonym Active Entire term case insensitive SNOMED CT core module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    2 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    2 Is a Number false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 milligram/1 milliliter and guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely fluconazole 2 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely epinephrine 10 microgram/1 milliliter and mepivacaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely paracetamol 650 milligram and pentazocine 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely clemastine fumarate 670 microgram and phenylpropanolamine 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely chlorpromazine hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and prilocaine hydrochloride 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely corbadrine 50 microgram/1 milliliter and mepivacaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextromethorphan hydrobromide 60 milligram and guaifenesin 1.2 gram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Has concentration strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing only neomycin and prednisolone in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only betamethasone and neomycin in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only betamethasone and neomycin in nasal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only hydrocortisone and neomycin in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only neomycin and prednisolone in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only acetic acid and oxyquinoline in vaginal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only acetic acid and oxyquinoline (medicinal product) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely menthol 30 microgram/1 milligram and methyl salicylate 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cefoperazone (as cefoperazone sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely ceftizoxime (as ceftizoxime sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely piperacillin anhydrous (as piperacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely lidocaine 25 milligram/1 milliliter and prilocaine 25 milligram/1 milliliter conventional release dental gel (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cilastatin (as cilastatin sodium) 250 milligram and imipenem anhydrous (as imipenem) 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely cefmetazole (as cefmetazole sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely coagulation factor VIII 500 unit and von Willebrand factor 1250 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely mezlocillin (as mezlocillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength numerator value False 2 Inferred relationship Existential restriction modifier 1
    Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only mequinol and tretinoin in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only aspirin and glycine in oromucosal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only loteprednol and tobramycin in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only calcium phosphate and carmellose in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only ciprofloxacin and dexamethasone in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only dextromethorphan and promethazine in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only fenoterol and ipratropium in pulmonary dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only fluorescein stain and proxymetacaine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only Frangula and Sterculia gum in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only fluorometholone and tobramycin in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only diiodohydroxyquinoline and hydrocortisone in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only ampicillin and sulbactam in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only salicylic acid and zinc oxide in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only betamethasone and calcipotriol in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only mucin and xylitol in oromucosal dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only naphazoline and pheniramine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only acetic acid and hydrocortisone in otic dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only brimonidine and timolol in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only coal tar and lecithin in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only bromazine and codeine in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only nicotinic acid and simvastatin in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only cocaine and epinephrine in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only hydrocortisone and pramocaine in cutaneous dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only hydroxyamfetamine and tropicamide in ocular dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only epinephrine and etidocaine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only codeine and kaolin in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only epinephrine and mepivacaine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only bupivacaine and epinephrine in parenteral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only ipratropium and salbutamol in pulmonary dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier
    Product containing only esterified estrogen and methyltestosterone in oral dose form (medicinal product form) Count of base of active ingredient False 2 Inferred relationship Existential restriction modifier

    Start Previous Page 22 of 35 Next End

    This concept is not in any reference sets

    Back to Start